Overview of Nanotechnology Drug Delivery MarketThe global Nanotechnology Drug Delivery Market is valued at USD 97.98 Billion ...

Artificial intelligence (AI) has moved in recent years from the realm of science fiction to a part of everyday life, incorporated into everything from search engines to virtual assistants to ...

Democrats and Republicans alike have concerns about AI and want to see the rapidly developing technology regulated to protect ...

Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

Generative AI is reshaping industries at a breakneck pace, but with this rapid ascension has come new challenges: how to fund, scale and allocate the compute infrastructure needed to power it.

The recent Hubbis webinar, co - hosted with the (DET), brought together leading voices in private wealth management, legal structuring, and family office advisory to explore Dubai’s evolution as a ...

The visit—Huang’s third to China this year—coincided with a series of significant developments: regulatory approval for ...

The global race to harness the power of artificial intelligence (AI) has begun. President Donald Trump got it right from the ...

While states like Texas and California create and vote on AI regulation, the federal government has stayed quiet. Congress’ current version of Trump’s “big beautiful bill” includes a federal ...

AI analysis flags LINK, ADA, and AVAX as undervalued, projecting 44%–264% upside within 30 days on rising interest.

The focus on artificial intelligence, part of a partnership with Google, raises concerns among some environmentalists and ...